ArticleRheumatology (Oxford, England)2025

Belimumab efficacy in mucocutaneous manifestations of systemic lupus erythematosus: a large post hoc analysis of five phase III clinical trials.

Giorgia Grosso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.